Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Operating Income: 2023-2024

Historic Operating Income for Pyxis Oncology (PYXS) over the last 2 years, with Dec 2024 value amounting to -$89.5 million.

  • Pyxis Oncology's Operating Income rose 1.23% to -$23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$106.2 million, marking a year-over-year change of. This contributed to the annual value of -$89.5 million for FY2024, which is 8.84% down from last year.
  • Latest data reveals that Pyxis Oncology reported Operating Income of -$89.5 million as of FY2024, which was down 8.84% from -$82.2 million recorded in FY2023.
  • In the past 5 years, Pyxis Oncology's Operating Income registered a high of -$82.2 million during FY2023, and its lowest value of -$89.5 million during FY2024.
  • Its 2-year average for Operating Income is -$85.8 million, with a median of -$85.8 million in 2023.
  • Data for Pyxis Oncology's Operating Income shows a maximum YoY decreased of 8.84% (in 2024) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Operating Income (Yearly) stood at -$82.2 million in 2023, then fell by 8.84% to -$89.5 million in 2024.